Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Calculate exactly how many units of Tesamorelin to draw on your syringe. Pre-filled with standard defaults.
Draw on your syringe
56.00
units
(0.560 mL)
56.0% of syringe capacity
Concentration
2,500
mcg/mL
Dose volume
0.560
mL
Doses per vial
3
doses
Cost per dose
---
enter price
Total mcg in vial = 5 mg x 1000 = 5,000 mcg
Concentration = 5,000 mcg / 2 mL = 2,500 mcg/mL
Dose volume = 1400 mcg / 2,500 mcg/mL = 0.5600 mL
Units to draw = 0.5600 mL x 100 units/mL = 56.00 units
Doses per vial = 5,000 mcg / 1400 mcg = 3.57 doses
Want the full Disclosed Trust Index?
Create a free account to unlock vendor trust scores, the COA scanner, the Forgery Map, and lot lookup across the corpus.
Create a free accountTesamorelin (Egrifta / Egrifta SV) is a stabilized analog of human GHRH(1-44) with a trans-3-hexenoic acid moiety at the N-terminus that protects against protease degradation. FDA-approved in November 2010 for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy, it is the only FDA-approved GHRH analog for this indication. Off-label use for general body composition and visceral fat reduction in non-HIV populations is common but outside the approved label.
Common vial size
5
mg
Typical BAC water
2
mL
Dose range
1400–2000
mcg
Default dose
1400
mcg
Store refrigerated (2-8°C). Once reconstituted, use within 28 days.
Disclosed Labs